Close Menu

NEW YORK (GenomeWeb News) – Beckman Coulter said after the close of the market on Tuesday that it has received CLIA certification and Massachusetts State Licensure, allowing its genomics operations to begin accepting clinical samples for genetic sequencing.

As a result, Beckman Coulter Genomics will be able to provide sequencing results to doctors for the treatment, diagnosis and prevention of disease in patients, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.